Table of Contents
Table 5-44: LaGrange
Table 5-46: LaPorte
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 1,243 | 559.4 | 6,483 | 596.9 | 503 | 234.8 | 2,945 | 281.2 |
| Esophagus | 28 | 12.9 | 118 | 10.6 | 12 | 5.6** | 80 | 7.3 |
| Stomach | 27 | 12.8 | 127 | 12.1 | 9 | 4.5** | 73 | 7.1 |
| Colon excluding Rectum | 117 | 54.4 | 561 | 53.3 | 48 | 22.8 | 307 | 29.5 |
| Rectum and Rectosigmoid Junction | 58 | 26.1 | 216 | 19.6 | 11 | 5.0** | 44 | 4.2 |
| Liver | 18 | 7.4** | 102 | 9.0 | 14 | 6.1** | 71 | 6.4 |
| Pancreas | 26 | 12.3 | 161 | 14.9 | 31 | 14.2 | 167 | 15.7 |
| Lung and Bronchus | 204 | 90.4 | 1,097 | 100.6 | 168 | 76.3 | 910 | 84.5 |
| Melanoma of the Skin | 20 | 9.1 | 128 | 11.5 | 5 | 2.2** | 30 | 2.8 |
| Prostate | 371 | 164.6 | 1,945 | 178.9 | 53 | 26.7 | 338 | 35.3 |
| Urinary Bladder | 70 | 32.7 | 377 | 35.5 | 13 | 6.1** | 68 | 7.0 |
| Kidney and Renal Pelvis | 37 | 16.8 | 206 | 18.9 | 13 | 6.1** | 86 | 8.3 |
| Brain and Other Nervous System | 10 | 4.6** | 75 | 6.6 | 7 | 2.9** | 61 | 5.5 |
| Non-Hodgkin Lymphoma | 43 | 19.5 | 239 | 21.7 | 11 | 5.0** | 102 | 9.5 |
| Myeloma | 12 | 5.0** | 84 | 7.7 | 12 | 5.5** | 66 | 6.3 |
| Leukemia | 38 | 17.0 | 183 | 16.8 | 19 | 9.5** | 111 | 10.9 |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 1,168 | 409.2 | 6,051 | 429.8 | 508 | 171.5 | 2,634 | 181.5 |
| Colon excluding Rectum | 100 | 34.1 | 552 | 37.7 | 60 | 19.7 | 231 | 15.4 |
| Rectum and Rectosigmoid Junction | 41 | 13.7 | 157 | 10.8 | 6 | 2.1** | 36 | 2.5 |
| Liver | 5 | 1.8** | 32 | 2.3 | * | # | 32 | 2.2 |
| Pancreas | 37 | 12.5 | 168 | 11.5 | 36 | 12.1 | 163 | 11.1 |
| Lung and Bronchus | 170 | 59.1 | 826 | 57.8 | 110 | 37.4 | 629 | 43.5 |
| Melanoma of the Skin | 20 | 7.1 | 91 | 6.7 | * | # | 23 | 1.6 |
| Breast | 326 | 114.8 | 1,737 | 125.3 | 86 | 29.3 | 463 | 32.3 |
| Cervix Uteri | 29 | 11.4 | 134 | 10.5 | 8 | 3.0** | 42 | 3.1 |
| Corpus Uteri | 65 | 22.7 | 368 | 26.3 | 7 | 2.4** | 33 | 2.3 |
| Ovary | 30 | 10.8 | 174 | 12.7 | 24 | 8.3 | 125 | 8.7 |
| Urinary Bladder | 28 | 9.3 | 149 | 10.1 | 11 | 3.6** | 42 | 2.7 |
| Kidney and Renal Pelvis | 24 | 8.6 | 159 | 11.3 | 8 | 2.8** | 53 | 3.6 |
| Brain and Other Nervous System | 11 | 4.0** | 68 | 5.0 | 7 | 2.5** | 37 | 2.7 |
| Non-Hodgkin Lymphoma | 38 | 13.2 | 233 | 16.7 | 19 | 6.2** | 84 | 5.8 |
| Myeloma | 16 | 5.5** | 76 | 5.2 | 7 | 2.3** | 42 | 2.8 |
| Leukemia | 26 | 9.1 | 153 | 10.8 | 14 | 4.4** | 87 | 5.8 |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, June 2007
Table of Contents
Table 5-44: LaGrange
Table 5-46: LaPorte
